Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study

Rogier Wvan der Zanden; Frank de Vries; Arief Lalmohamed; Johanna H. M. Driessen; Anthonius de Boer; Gernot Rohde; Cees Neef; Casper den Heijer

doi:10.1371/journal.pone.0139367

Loading metrics

Open Access

Peer-reviewed

Research Article

Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study

Rogier Wvan der Zanden,

Affiliations Department of Clinical Pharmacy and Toxicology, Maastricht University, Medical Centre+, Maastricht, Netherlands, Care and Public Health Research Institute (CAPHRI), Maastricht, Netherlands
⨯
Frank de Vries ,

* E-mail: f.devries@uu.nl

Affiliations Department of Clinical Pharmacy and Toxicology, Maastricht University, Medical Centre+, Maastricht, Netherlands, Care and Public Health Research Institute (CAPHRI), Maastricht, Netherlands, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands
⨯
Arief Lalmohamed,

Affiliations Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands, Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands
⨯
Johanna H. M. Driessen,

Affiliations Department of Clinical Pharmacy and Toxicology, Maastricht University, Medical Centre+, Maastricht, Netherlands, Care and Public Health Research Institute (CAPHRI), Maastricht, Netherlands, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands
⨯
Anthonius de Boer,

Affiliation Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands; Department of Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, The Netherlands
⨯
Gernot Rohde,

Affiliation Department of Respiratory Medicine, Maastricht University, Medical Centre+, Maastricht, Netherlands
⨯
Cees Neef,

Affiliations Department of Clinical Pharmacy and Toxicology, Maastricht University, Medical Centre+, Maastricht, Netherlands, Care and Public Health Research Institute (CAPHRI), Maastricht, Netherlands
⨯
Casper den Heijer

Affiliations Department of Sexual Health, Infectious Diseases and Environmental Health, Public Health Service South Limburg, Geleen, Netherlands, Department of Microbiology, Maastricht University Medical Centre+, Maastricht, Netherlands
⨯

Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study

Rogier Wvan der Zanden,
Frank de Vries,
Arief Lalmohamed,
Johanna H. M. Driessen,
Anthonius de Boer,
Gernot Rohde,
Cees Neef,
Casper den Heijer

Published: October 15, 2015
https://doi.org/10.1371/journal.pone.0139367

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Pneumonia
Is the Subject Area "Pneumonia" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Upper respiratory tract infections
Is the Subject Area "Upper respiratory tract infections" applicable to this article?

Thanks for your feedback.
Cancer risk factors
Is the Subject Area "Cancer risk factors" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Type 2 diabetes risk
Is the Subject Area "Type 2 diabetes risk" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.